Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. 

Biotechnology

Sensorium Therapeutics

Dick Simon

Sherry Rais

Steve Haggarty

Pranav Tadi

Michael Placzek

Jerry Rosenbaum

Jeffrey Brown

Jacob Hooker

Alex Simon

The Research and Sciences team at Sensorium Therapeutics focuses on leveraging advanced chemistry, neuroscience, and machine learning to develop and refine nature-derived psychoactive medicines for mental health. The team conducts foundational research, computational biology analysis, drug metabolism and pharmacokinetics studies, and neuroscientific investigations to identify and enhance key molecules for therapeutic use. Their combined efforts aim to revolutionize mental health treatment through innovative, plant and fungi-based solutions.

Research and Sciences

Board Members and Directors

Leadership Team

Research and Sciences

About

Team members

Other teams at Sensorium Therapeutics

Board Members and Directors

Leadership Team